Skip to main content
Loading

AI/ML in antibody discovery, engineering and lead optimization

18 Nov 2024
Lead Identification & Optimization
AI/ML in antibody discovery, engineering and lead optimization
  • How can we increase hit diversity from screening outputs using NGS with AI/ML?
  • How can improve antibody engineering with AI/ML?
  • How can we optimize lead candidates for manufacturability and developability with AI/ML support?
  • How can we integrate experimental workflows with AI/ML?
  • Facilitator Name: Thomas Schirrmann, PhD
Industry Expert
Thomas Schirrmann, CEO & Co-Founder - YUMAB